Skip to main content

Table 2 Clinical and medication characteristics of study participants in the Amhara region public hospitals (2010–2016)

From: Predictors of CD4 count changes over time among children who initiated highly active antiretroviral therapy in Ethiopia

VariableCategoryNumber%
Regimen typed4T + 3TC + NVP32734.3
d4T + 3TC + EFV768.0
AZT + 3TC + NVP33334.9
AZT + 3TC + EFV16016.8
Others555.8
Functional statusWorking32333.9
Ambulatory46248.4
Bedridden16617.5
BWHO stageStage I28629.9
Stage II30932.4
Stage III28730.1
Stage IV697.2
DisclosureYes72075.7
No23124.3
Opportunistic infectionYes69172.7
No26027.3
MARV statusYes90995.6
No424.4
Medication adherencePoor29138.04
Fair11715.29
Good35746.67
  1. BWHO baseline WHO stage, MARV mothers’ antiretroviral